Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boyd

Showing results (441-450 of 476) with videos related to

Pageof 48
Sort By:
EMBO Molecular Medicine|February 22, 2021
Novel AAV capsids for intravitreal gene therapy of photoreceptor disordersMarina Pavlou, Christian Schön, Laurence M Occelli, et al.
Science (New York, N.Y.)|July 31, 1970
Apollo 11: exposure of lower animals to lunar materialC A Benschoter, T C Allison, J F Boyd, et al.
Journal of the National Cancer Institute|April 5, 2017
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer RiskCelia Byrne, Giske Ursin, Christopher F Martin, et al.
Research Square|December 3, 2025
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunityJiansheng Jiang, Abir K Panda, Kannan Natarajan, et al.
Communications Biology|February 2, 2026
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunityJiansheng Jiang, Abir K Panda, Kannan Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.
Cell Host & Microbe|October 18, 2016
DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell DeathRoshan J Thapa, Justin P Ingram, Katherine B Ragan, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2)J C Bloomer, H F Boyd, D M Hickey, et al.
Advances in Kidney Disease and Health|April 13, 2025
Postdischarge Care of Acute Kidney Injury Survivors: An Opportunity for Targeted Nurse and Pharmacist InterventionsMelanie M Manis, Jessica L Wallace, Emily F Boyd, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2026
Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injectionEva Andres-Mateos, Christopher Kozlowski, Hangning Zhang, et al.
Pageof 48

Showing results (441-450 of 476) with videos related to

Sort By:
Pageof 48
EMBO Molecular Medicine|February 22, 2021
Novel AAV capsids for intravitreal gene therapy of photoreceptor disordersMarina Pavlou, Christian Schön, Laurence M Occelli, et al.
Science (New York, N.Y.)|July 31, 1970
Apollo 11: exposure of lower animals to lunar materialC A Benschoter, T C Allison, J F Boyd, et al.
Journal of the National Cancer Institute|April 5, 2017
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer RiskCelia Byrne, Giske Ursin, Christopher F Martin, et al.
Research Square|December 3, 2025
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunityJiansheng Jiang, Abir K Panda, Kannan Natarajan, et al.
Communications Biology|February 2, 2026
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunityJiansheng Jiang, Abir K Panda, Kannan Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.
Cell Host & Microbe|October 18, 2016
DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell DeathRoshan J Thapa, Justin P Ingram, Katherine B Ragan, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2)J C Bloomer, H F Boyd, D M Hickey, et al.
Advances in Kidney Disease and Health|April 13, 2025
Postdischarge Care of Acute Kidney Injury Survivors: An Opportunity for Targeted Nurse and Pharmacist InterventionsMelanie M Manis, Jessica L Wallace, Emily F Boyd, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2026
Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injectionEva Andres-Mateos, Christopher Kozlowski, Hangning Zhang, et al.
Pageof 48